US6706571055

Taking everything into account, **NEA** scores **2** out of 10 in our fundamental rating. **NEA** was compared to 0 industry peers in the **Unkown** industry. The financial health of **NEA** is average, but there are quite some concerns on its profitability. **NEA** does not seem to be growing, but still is valued expensively.

In the past year **NEA** was profitable.

In the past year **NEA** had a positive cash flow from operations.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -0.21% | ||

ROE | -0.21% | ||

ROIC | 1.95% |

ROA(3y)-4.42%

ROA(5y)-0.51%

ROE(3y)-4.7%

ROE(5y)-0.62%

ROIC(3y)2.11%

ROIC(5y)2.14%

In the last couple of years the **Profit Margin** of **NEA** has declined.

In the last couple of years the **Gross Margin** of **NEA** has declined.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 57.58% | ||

PM (TTM) | N/A | ||

GM | 57.7% |

OM growth 3Y-11.62%

OM growth 5Y-6.09%

PM growth 3Y-40.19%

PM growth 5YN/A

GM growth 3Y-11.59%

GM growth 5Y-6.07%

The Debt to FCF ratio of **NEA** is **0.23**, which is an excellent value as it means it would take **NEA**, only **0.23** years of fcf income to pay off all of its debts.

A Debt/Equity ratio of **0.01** indicates that **NEA** is not too dependend on debt financing.

Although **NEA** does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.01 | ||

Debt/FCF | 0.23 | ||

Altman-Z | 16.82 |

ROIC/WACCN/A

WACCN/A

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 1.12 | ||

Quick Ratio | 1.12 |

The **Revenue** has been growing slightly by **1.87%** in the past year.

Measured over the past years, **NEA** shows a decrease in **Revenue**. The Revenue has been decreasing by **0.00%** on average per year.

EPS 1Y (TTM)102.49%

EPS 3Y-41.91%

EPS 5YN/A

EPS Q2Q%49.74%

Revenue 1Y (TTM)1.87%

Revenue growth 3Y-0.34%

Revenue growth 5Y0%

Sales Q2Q%-0.14%

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

A **Price/Earnings** ratio of **99.17** indicates a quite expensive valuation of **NEA**.

Compared to an average S&P500 **Price/Earnings** ratio of **31.52**, **NEA** is valued quite expensively.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 99.17 | ||

Fwd PE | N/A |

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 9.24 | ||

EV/EBITDA | N/A |

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

With a **Yearly Dividend Yield** of **5.15%**, **NEA** is a good candidate for dividend investing.

Compared to an average S&P500 **Dividend Yield** of **2.22**, **NEA** pays a better dividend.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 5.15% |

The dividend of **NEA** decreases each year by **-8.06%**.

The dividend of **NEA** decreased recently.

Dividend Growth(5Y)-8.06%

Div Incr Years1

Div Non Decr Years1

The earnings of **NEA** are negative and hence is the payout ratio. **NEA** will probably not be able to sustain this dividend level.

DP-1261.83%

EPS Next 2YN/A

EPS Next 3YN/A

**NUVEEN AMT-FR QLTY MUNI INC**

NYSE:NEA (10/14/2024, 10:06:05 AM)

**11.9**

**-0.02 (-0.17%) **

Chartmill FA Rating

GICS SectorN/A

GICS IndustryGroupN/A

GICS IndustryN/A

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap3.56B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 5.15% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 99.17 | ||

Fwd PE | N/A | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -0.21% | ||

ROE | -0.21% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 57.58% | ||

PM (TTM) | N/A | ||

GM | 57.7% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.04

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.01 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 1.12 | ||

Quick Ratio | 1.12 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)102.49%

EPS 3Y-41.91%

EPS 5Y

EPS Q2Q%

EPS Next YN/A

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)1.87%

Revenue growth 3Y-0.34%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y